Stay updated on Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial page.

Latest updates to the Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedLocations section updated with new sites in California, Florida, Illinois, Maryland, Massachusetts, New York, Ohio, Oregon, Pennsylvania, Tennessee, Texas, Washington, Ontario, and Michigan, and removals from the list (revision 3.3.3 vs 3.3.2).SummaryDifference1%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2; no substantive study content was changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page now displays Revision: v3.3.1, replacing Revision: v3.2.0.SummaryDifference0.0%

- Check56 days agoChange DetectedThe government funding lapse notice/operating-status statement has been removed from the page. This change does not alter the study details or how a user would engage with the trial information.SummaryDifference0.3%

- Check70 days agoChange DetectedResults data and updated study record dates have been added to the page, including the results posting date. The page now presents core trial information that was previously unavailable.SummaryDifference0.3%

- Check100 days agoChange DetectedPage updated to Revision: v3.2.0 from Revision: v3.0.2; indicates a new release version with no other substantive content changes.SummaryDifference0.0%

Stay in the know with updates to Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial page.